Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 07 1997, 1604-1606, Vol 41, No. 7
AS Peregrine, MA Gray and SK Moloo
Resistance to isometamidium was increased 94-fold in a clone of Trypanosoma
congolense (clone IL 1180) by repeated subcurative treatment of infected
mice for 11 months. This was associated with 3.4- , 33-, and 4.2-fold
increases in resistance to diminazene, homidium, and quinapyramine,
respectively. Both T. congolense IL 1180 and the resistant derivative were
able to undergo cyclical development in Glossina morsitans centralis tsetse
flies, producing hypopharyngeal infection rates of 40.0 and 39.8%,
respectively.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Cross-resistance associated with development of resistance to isometamidium in a clone of Trypanosoma congolense
International Livestock Research Institute, Nairobi, Kenya. aperegrine@ovcnet.uoguelph.ca
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |